COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02826772
Recruitment Status : Completed
First Posted : July 11, 2016
Last Update Posted : March 17, 2020
Information provided by (Responsible Party):
Suzhou Kintor Pharmaceutical Inc,

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 15, 2019
Actual Study Completion Date : February 15, 2020